Cargando…

Knowledge, Attitude, and Practice of Metformin Extended-Release Tablets Among Clinicians in China: A Cross-Sectional Survey

Background: Metformin extended-release (XR) is a once-daily alternative conventional immediate-release (IR) tablet for adults with type 2 diabetes. Aim: This study aimed to investigate the knowledge, attitude, and practice of the use of metformin XR tablets among clinicians. Methods: We conducted a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Chang, Tang, Siqi, An, Kang, Zhang, Shengzhao, Zhou, Yiling, Su, Na, Yang, Rong, Liao, Xiaoyang, An, Zhenmei, Li, Sheyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312381/ https://www.ncbi.nlm.nih.gov/pubmed/34322016 http://dx.doi.org/10.3389/fphar.2021.634561

Ejemplares similares

Long-Acting Metformin Vs. Metformin Immediate Release in Patients With Type 2 Diabetes: A Systematic Review
por: Tan, Jixue, et al.
Publicado: (2021)

Pharmacokinetic comparison of sitagliptin and metformin HCl extended-release tablets versus JANUMET(®) XR in healthy volunteers under fasting and fed conditions
por: Que, Linling, et al.
Publicado: (2023)

Cardiovascular Safety of Febuxostat and Allopurinol in Hyperuricemic Patients With or Without Gout: A Network Meta-Analysis
por: Zhang, Shengzhao, et al.
Publicado: (2021)

Formulation and evaluation of bilayer tablet for bimodal release of venlafaxine hydrochloride
por: Momin, Munira M., et al.
Publicado: (2015)

Bioequivalence and safety evaluation of two preparations of metformin hydrochloride sustained-release tablets (Boke(®) and Glucophage(®)-XR) in healthy Chinese volunteers: a randomized phase I clinical trial
por: Sun, Ming-Li, et al.
Publicado: (2022)

Guideline Adherence of β-blocker Initiating Dose and its Consequence in Hospitalized Patients With Heart Failure With Reduced Ejection Fraction
por: Zhou, Yiling, et al.
Publicado: (2021)

Deficiencies in Planning Interventional Trial Registration of COVID-19 in China
por: Li, Xiaodan, et al.
Publicado: (2021)

Sodium-Glucose Co-Transporter-2 Inhibitors in Non-Diabetic Adults With Overweight or Obesity: A Systematic Review and Meta-Analysis
por: Zheng, Hanrui, et al.
Publicado: (2021)

Preparation of Colon-Targeted Acetylharpagide Tablets and its Release Properties in vivo and in vitro
por: Liu, DeWen, et al.
Publicado: (2018)

Additive Manufacturing of an Extended-Release Tablet of Tacrolimus
por: Abdollahi, Azin, et al.
Publicado: (2023)

Metoprolol succinate extended release/hydrochlorothiazide combination tablets
por: Hainer, James W, et al.
Publicado: (2007)

Comparison of Clinical Efficacy and Safety of Metformin Sustained-Release Tablet (II) (Dulening) and Metformin Tablet (Glucophage) in Treatment of Type 2 Diabetes Mellitus
por: Guo, Li-xin, et al.
Publicado: (2021)

Safety of liposome extended-release bupivacaine for postoperative pain control
por: Portillo, Juan, et al.
Publicado: (2014)

Nation-Wide Survey Assessing the Knowledge and Attitudes of Romanian Pharmacists Concerning Pharmacogenetics
por: Pop, Cristina, et al.
Publicado: (2022)

Water hyacinth: a possible alternative rate retarding natural polymer used in sustained release tablet design
por: Khatun, Sabera, et al.
Publicado: (2014)

Design of bilayer tablets using modified Dioscorea starches as novel excipients for immediate and sustained release of aceclofenac sodium
por: Okunlola, Adenike
Publicado: (2015)

The Effect of Rotigotine Extended-Release Microspheres Alone or With Celecoxib on the Inflammatory Pain
por: Li, Keke, et al.
Publicado: (2020)

Useful Extend-release Chitosan Tablets with High Antioxidant Activity
por: Yasufuku, Taira, et al.
Publicado: (2010)

Development and bioequivalence study of potassium chloride extended release tablets
por: Le Thi, Thu Van, et al.
Publicado: (2018)

Development of Biopredictive Dissolution Method for Extended-Release Desvenlafaxine Tablets
por: Carapeto, Gustavo Vaiano, et al.
Publicado: (2023)

Retraction: Water hyacinth: a possible alternative rate retarding natural polymer used in sustained release tablet design
Publicado: (2016)

Tacrolimus Intrapatient Variability After Switching From Immediate or Prolonged-Release to Extended-Release Formulation, After an Organ Transplantation
por: Del Bello, Arnaud, et al.
Publicado: (2021)

The Effect of Once-Daily Gabapentin Extended Release Formulation in Patients With Postamputation Pain
por: Knezevic, Nebojsa Nick, et al.
Publicado: (2019)

Expression of Concern: Water hyacinth: a possible alternative rate retarding natural polymer used in sustained release tablet design
Publicado: (2016)

A knowledge, attitude, and practice survey on mediation among clinicians in a tertiary-care hospital in Singapore
por: Lin, Wenrong, et al.
Publicado: (2018)

Prevalence Estimates for Pharmacological Neuroenhancement in Austrian University Students: Its Relation to Health-Related Risk Attitude and the Framing Effect of Caffeine Tablets
por: Dietz, Pavel, et al.
Publicado: (2018)

Pharmacological and toxicological studies of a novel goserelin acetate extended-release microspheres in rats
por: Yutong, Mao, et al.
Publicado: (2023)

Formulation Development and Stability Studies of Norfloxacin Extended-Release Matrix Tablets
por: Oliveira, Paulo Renato, et al.
Publicado: (2013)

Development of In Vitro–In Vivo Correlation for Upadacitinib Extended-Release Tablet Formulation
por: Mohamed, Mohamed-Eslam F., et al.
Publicado: (2019)

Deciphering the Roles of Metformin in Alzheimer’s Disease: A Snapshot
por: Liao, Wang, et al.
Publicado: (2022)

Danlu tongdu tablets: Preclinical safety evaluation and mechanism of hepatotoxicity
por: Zhang, Haijing, et al.
Publicado: (2022)

Development and Validation of Discriminative Dissolution Method for Metformin Immediate-Release Film-Coated Tablets
por: Mitrevska, Ivana, et al.
Publicado: (2019)

Effect of Excipients on the Quality of Drug Formulation and Immediate Release of Generic Metformin HCl Tablets
por: Arafat, Mosab, et al.
Publicado: (2023)

Formulation and Evaluation of Extended-Release Solid Dispersion of Metformin Hydrochloride
por: Patil, SA, et al.
Publicado: (2010)

Cardiovascular safety of febuxostat and allopurinol in patients with gout: A meta-analysis
por: Guan, Xudong, et al.
Publicado: (2022)

Response Surface Optimization of Sustained Release Metformin-Hydrochloride Matrix Tablets: Influence of Some Hydrophillic Polymers on the Release
por: Roy, Amitava, et al.
Publicado: (2012)

Correction: A knowledge, attitude, and practice survey on mediation among clinicians in a tertiary-care hospital in Singapore
por: Lin, Wenrong, et al.
Publicado: (2018)

Pharmacokinetic Equivalence of the High Dose Strength Fixed-Dose Combination Tablet of Gemigliptin/Metformin Sustained Release (SR) and Individual Component Gemigliptin and Metformin XR Tablets in Healthy Subjects
por: Cho, Yong-Soon, et al.
Publicado: (2018)

Efficacy, Safety, and Retention Rate of Extended-Release Divalproex Versus Conventional Delayed-Release Divalproex: A Meta-Analysis of Controlled Clinical Trials
por: Zhang, Chen Qi, et al.
Publicado: (2022)

Biorelevant In Vitro Release Testing and In Vivo Study of Extended-Release Niacin Hydrophilic Matrix Tablets
por: Milanowski, Bartłomiej, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1svhpbbmo0k60heqldabbnuje2